Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.020
+0.410 (25.47%)
At close: Mar 6, 2026, 4:00 PM EST
2.000
-0.020 (-0.99%)
After-hours: Mar 6, 2026, 7:59 PM EST

Pulmonx Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
83912704913171,184
Market Cap Growth
-75.97%-66.26%-44.99%55.12%-73.27%-51.92%
Enterprise Value
69.9376.3224.1412.09196.41,028
Last Close Price
2.022.216.7912.758.4332.07
PE Ratio
--1.66-4.72-7.97-5.30-23.76
PS Ratio
0.921.013.227.155.9024.46
PB Ratio
1.551.683.154.152.066.13
P/TBV Ratio
1.521.663.104.092.036.00
P/FCF Ratio
---8.19-12.78-6.82-26.29
P/OCF Ratio
---8.57-13.06-7.02-28.62
EV/Sales Ratio
0.770.842.676.003.6621.24
EV/EBITDA Ratio
--1.42-3.99-6.82-3.44-22.15
EV/EBIT Ratio
--1.42-3.88-6.65-3.35-21.74
EV/FCF Ratio
---6.79-10.73-4.23-22.82
Debt / Equity Ratio
1.021.020.650.320.140.13
Debt / EBITDA Ratio
-1.05-1.05-1.00-0.69-0.43-0.57
Debt / FCF Ratio
---1.71-1.08-0.53-0.59
Net Debt / Equity Ratio
-0.25-0.25-0.53-0.64-0.76-0.80
Net Debt / EBITDA Ratio
0.250.250.811.262.053.31
Net Debt / FCF Ratio
--1.371.982.523.41
Asset Turnover
0.620.620.490.370.250.19
Inventory Turnover
1.231.231.150.920.760.95
Quick Ratio
4.094.094.705.598.1110.65
Current Ratio
5.075.075.586.509.1411.85
Return on Equity (ROE)
-77.19%-77.19%-55.25%-44.68%-33.94%-23.21%
Return on Assets (ROA)
-37.17%-37.17%-34.18%-33.66%-27.51%-19.10%
Return on Invested Capital (ROIC)
-133.02%-133.02%-139.41%-156.34%-152.77%-154.31%
Return on Capital Employed (ROCE)
-43.34%-43.34%-39.38%-37.56%-29.86%-20.18%
Earnings Yield
-64.81%-60.18%-21.21%-12.55%-18.86%-4.21%
FCF Yield
-0.00%-12.21%-7.82%-14.66%-3.80%
Buyback Yield / Dilution
-0.00%-0.54%-0.30%-0.81%-0.38%
Updated Dec 31, 2025. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q